HES3 and type 2 diabetes mellitus: Here we used a mouse model of type 1 diabetes mellitus (the streptozotocin-induced β-cell damage model), a mouse model of high fat diet exhibiting systemic inflammation and insulin resistance, often used to study aspects of type 2 diabetes, and a mouse model of metformin administration to establish the transcription factor Hes3 as such a biomarker.